Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Antimicrobial Agents|November 26, 2009
Short-course therapy for bloodstream infections in immunocompetent adultsG Ralph Corey, Martin E Stryjewski, Richard J Everts
Infection and Immunity|July 26, 2005
Fsr-independent production of protease(s) may explain the lack of attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of endocarditisKavindra V Singh, Sreedhar R Nallapareddy, Esteban C Nannini, et al.
The Journal of Infection|July 9, 2002
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquineEsteban C Nannini, Michael Keating, Peter Binstock, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2013
<i>In Vivo</i> Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against CefazolinEsteban C Nannini, Kavindra V Singh, Cesar A Arias, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis modelEsteban C Nannini, Suresh R Pai, Kavindra V Singh, et al.
Expert Opinion on Pharmacotherapy|November 15, 2011
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumoniaEthan Rubinstein, G Ralph Corey, Martin E Stryjewski, et al.
Current Infectious Disease Reports|July 22, 2004
Issues in the Management of Endocarditis Caused by Resistant Gram-positive OrganismsMartin E. Stryjewski, Vivian H. Chu, Christopher H. Cabell, et al.
Chest|December 7, 2021
A 31-Year-Old Man With Seizures, Brain Lesion, and Lung NodulesLuis Patricio Maskin, Matias H Garcia Hernandez, Martin E Stryjewski, et al.
Scandinavian Journal of Infectious Diseases|August 18, 2009
Nephrotoxicity associated with the use of intravenous colistinCecilia Santamaría, Analia Mykietiuk, Elena Temporiti, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA GuidanceRichard Pushkin, Steven L Barriere, Whedy Wang, et al.
Pageof 10